Publications - Jay A. Van Gerpen, M.D.

Back to research profile

  1. Labbe C, Soto-Ortolaza AI, Rayaprolu S, Harriott AM, Strongosky AJ, Uitti RJ, Van Gerpen JA, Wszolek ZK, Ross OA. Investigating the role of FUS exonic variants in Essential Tremor. Parkinsonism Relat Disord. 2013 Apr 16. [Epub ahead of print]
    View PubMed
  2. Dejesus-Hernandez M, Rayaprolu S, Soto-Ortolaza AI, Rutherford NJ, Heckman MG, Traynor S, Strongosky A, Graff-Radford N, Van Gerpen J, Uitti RJ, Shih JJ, Lin SC, Wszolek ZK, Rademakers R, Ross OA. Analysis of the C9orf72 repeat in Parkinson's disease, essential tremor and restless legs syndrome. Parkinsonism Relat Disord. 2013 Feb; 19(2):198-201. Epub 2012 Oct 18.
    View PubMed
  3. Van Gerpen JA, Rucker CT, Matthews M, Saucier MA. Lifting the "FOG" with laser generated visual-cueing. Neurologist. 2012 Sep; 18(5):298-301.
    View PubMed
  4. Sundal C, Van Gerpen JA, Nicholson AM, Wider C, Shuster EA, Aasly J, Spina S, Ghetti B, Roeber S, Garbern J, Borjesson-Hanson A, Tselis A, Swerdlow RH, Miller BB, Fujioka S, Heckman MG, Uitti RJ, Josephs KA, Baker M, Andersen O, Rademakers R, Dickson DW, MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 2012 Aug 7; 79(6):566-74. Epub 2012 Jul 25.
    View PubMed
  5. LeDoux MS, Xiao J, Rudzinska M, Bastian RW, Wszolek ZK, Van Gerpen JA, Puschmann A, Momcilovic D, Vemula SR, Zhao Y. Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat Disord. 2012 Jun; 18(5):414-25. Epub 2012 Feb 28.
    View PubMed
  6. Rademakers R, Baker M, Nicholson AM, Rutherford NJ, Finch N, Soto-Ortolaza A, Lash J, Wider C, Wojtas A, DeJesus-Hernandez M, Adamson J, Kouri N, Sundal C, Shuster EA, Aasly J, MacKenzie J, Roeber S, Kretzschmar HA, Boeve BF, Knopman DS, Petersen RC, Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet. 2012 Feb; 44(2):200-5. Epub 2011 Dec 25.
    View PubMed
  7. Wray S, Self M, NINDS Parkinson's Disease iPSC Consortium, NINDS Huntington's Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis PA, Taanman JW, Ryan NS, Mahoney CJ, Liang Y, Devine MJ, Sheerin UM, Houlden H, Morris HR, Healy D, Marti-Masso JF, Pre Creation of an open-access, mutation-defined fibroblast resource for neurological disease research. PLoS One. 2012; 7(8):e43099. Epub 2012 Aug 27.
    View PubMed
  8. Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW. Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies. Neurology. 2011 Aug 30; 77(9):875-82. Epub 2011 Aug 17.
    View PubMed
  9. Ross OA, Rutherford NJ, Baker M, Soto-Ortolaza AI, Carrasquillo MM, DeJesus-Hernandez M, Adamson J, Li M, Volkening K, Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio EH, Lippa C, Woodruff BK, Knopman DS, White CL 3rd, Van Gerpen JA, Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet. 2011 Aug 15; 20(16):3207-12. Epub 2011 May 24.
    View PubMed
  10. Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destee A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Kruger R, Lambert JC, Lohmann K, Independent and joint effects of the MAPT and SNCA genes in Parkinson disease. Ann Neurol. 2011 May; 69(5):778-92. Epub 2011 Mar 09.
    View PubMed
  11. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzinska M, Pfeiffer RF, Le C, LeDoux MS. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov Disord. 2011 Feb 15; 26(3):549-52. Epub 2011 Mar 02.
    View PubMed
  12. Van Gerpen JA. Office assessment of gait and station. Semin Neurol. 2011 Feb; 31(1):78-84. Epub 2011 Feb 14.
    View PubMed
  13. Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Dev Batish S, Blitzer A, Pfeiffer RF, Gong S, LeDoux MS. Novel THAP1 sequence variants in primary dystonia. Neurology. 2010 Jan 19; 74(3):229-38.
    View PubMed
  14. Shih JJ, LeslieMazwi T, Falcao G, Van Gerpen J. Directed aggressive behavior in frontal lobe epilepsy: a video-EEG and ictal spect case study. Neurology. 2009 Nov 24; 73(21):1804-6. Epub 2009 Oct 21.
    View PubMed
  15. Wider C, Van Gerpen JA, DeArmond S, Shuster EA, Dickson DW, Wszolek ZK. Leukoencephalopathy with spheroids (HDLS) and pigmentary leukodystrophy (POLD): a single entity? Neurology. 2009 Jun 2; 72(22):1953-9.
    View PubMed
  16. Van Gerpen JA, Wider C, Broderick DF, Dickson DW, Brown LA, Wszolek ZK. Insights into the dynamics of hereditary diffuse leukoencephalopathy with axonal spheroids. Neurology. 2008 Sep 16; 71(12):925-9.
    View PubMed
  17. Gros AJ Jr, Thomas LC, McKinley KL, Van Gerpen JA. Prevention of an acute severe exacerbation of Stiff-person syndrome during surgery. Anesthesiology. 2006 Apr; 104(4):885-6.
    View PubMed
  18. Van Gerpen JA, Kumar N, Bower JH, Weigand S, Ahlskog JE. Levodopa-associated dyskinesia risk among Parkinson disease patients in Olmsted County, Minnesota, 1976-1990. Arch Neurol. 2006 Feb; 63(2):205-9.
    View PubMed
  19. Van Gerpen JA. Dopa-responsive dystonic camptocormia. Neurology. 2006; 66:1779.
  20. Van Gerpen JA. A Review of The Parkinson’s Disease Treatment Book by Dr.J Eric Ahlskog Oxford University Press, 2005 Mayo Clin Proc. 2006.
  21. Kumar N, Van Gerpen JA, Bower JH, Ahlskog JE. Levodopa-dyskinesia incidence by age of Parkinson's disease onset. Mov Disord. 2005 Mar; 20(3):342-4.
    View PubMed
  22. Van Gerpen JA, Caruso S. Tick paralysis. Mayo Clin Proc. 2005; 80:938.
  23. Van Gerpen JA, Ahlskog JE, Petty GW. Progressive supranuclear palsy phenotype secondary to CADASIL. Parkinsonism & Related Disorders. 2003 Aug; 9(6):367-9.
    View PubMed
  24. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, Fleischauer A, Leis AA, Stokic DS, Petersen LR. Neurologic manifestations and outcome of West Nile virus infection. JAMA. 2003 Jul 23; 290(4):511-5.
    View PubMed
  25. Josephs KA, Van Gerpen MW, Van Gerpen JA. Adult onset Niemann-Pick disease type C presenting with psychosis. J Neurol Neurosurg Psychiatry. 2003 Apr; 74(4):528-9.
    View PubMed
  26. Van Gerpen JA, Dyck PJB, Dyck PJ. Cutaneous T-Cell lymphoma imitating gelsolin amyloidosis. Neurology. 2003; 60:861.
  27. Sejvar JJ, Leis A, Stovic DS, Van Gerpen JA, et al. Acute flaccid paralysis associated with West Nile virus infection. J Emerg Infect Dis. 2003; 9:788-93.
  28. Van Gerpen JA. Neurologic sequelae of West Nile virus infection. Ochsner Journal. 2003; 5:18-20.
  29. Elbaz A, Peterson BJ, Yang P, Van Gerpen JA, Bower JH, Maraganore DM, McDonnell SK, Ahlskog JE, Rocca WA. Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology. 2002 Mar; 13(2):157-64.
    View PubMed
  30. Sejvar JJ, Leis A, Van Gerpen JA, et al. Acute flaccid paralysis syndrome associated with west nile virus infection -- Mississippi and Louisiana, July-August 2002. MMWR. 2002; 51:825-8.
  31. Van Gerpen JA. Drug-induced parkinsonism. Neurolog. 2002; 8:363-70.
  32. Van Gerpen JA. Camptocormia secondary to early amyotrophic lateral sclerosis. Mov Disord. 2001 Mar; 16(2):358-60.
    View PubMed
  33. Van Gerpen JA, Goudreau JL, Dodick DW, Gertz MA. Amyloidosis presenting with intractable epistaxis and multiple cranial neuropathies. Neurology. 2000 Dec 12; 55(11):1755-6.
    View PubMed
  34. Van Gerpen JA, Matsumoto JY, Ahlskog JE, Maraganore DM, McManis PG. Utility of an EMG mapping study in treating cervical dystonia. Muscle Nerve. 2000 Nov; 23(11):1752-6.
    View PubMed
  35. Van Gerpen JA, Hickey S, Capobianco DJ. Migraine: Diagnosis, prevention and treatment. Jacksonville Medicine. 2000; 51(4):156-62.
  36. Van Gerpen JA, Kelly M, Fort DW. Multiple cranial neuropathies: unusual presentation of acute T-cell lymphoma. J Child Neurol. 1998 Apr; 13(4):185-7.
    View PubMed
  37. Van Gerpen JA. Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS. Neurology. 1997 Feb; 48(2):537-8.
    View PubMed


Appointments | Contact Us | Give to Mayo Clinic | Search

LEGAL RESTRICTIONS AND TERMS OF USE APPLICABLE TO THIS SITE

Use of this site signifies your agreement to the terms of use.
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.